ENANTA PHARMACEUTICALS INC

Pharmaceutical Preparations | SIC: 2834
Phone: 617 607 0800
CIK: 0001177648
EIN: 043205099
State Location: MA
Tickers:
  • Nasdaq:ENTA

Form: 4

Filing Date: 26 Nov 2025
Report Date: 25 Nov 2025
Accepted: 26 Nov 2025 08:08 p.m.
Accession Number: 0002064832-25-000030
Act: None
File Number: None
Film Number: None

Documents

Primary Document: STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Accepted: 26 Nov 2025 08:08 p.m.